Re:A cancer trial’s unexpected result: Remission in every pa...
by elhudy on Sunday June 05, 2022 @09:42PM
(#31636573)
BTK inhibitors are technically in 3rd gen (noncovalent) already if you can get in the trials (which are very promising considering they use the same mechanism).
[ Parent
| on HN ]
There are no comments on this comment yet.